Forest Labs Seen Needing Deal Amid Patent Loss: Real M&A

Forest Laboratories Inc. needs acquisitions to counter a projected 80 percent drop in profit this year as patents on its top-selling drugs start to expire.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.